Give Your Input on Impact of EU Clinical Trials Directive
ICREL allows you the opportunity to give your input through a survey about the EU Clinical Trials Directive.
Brussels, Belgium-June 9, 2008-ICREL is a one-year EU FP7 project, coordinated by EFGCP with further consortium members being EORTC under leadership of Denis Lacombe, ECRIN under leadership of Jacques Demotes, The Ethics Committee of the University of Vienna under leadership of Christiane Druml, and Hospital Clinic I de Barcelona under leadership of Xavier Carné. The project aims at analyzing the impact of the Clinical Trials Directive 2001/20/EC on clinical research in Europe.
ICREL has just launched a survey, giving sampled-out stakeholders (commercial and non-commercial sponsors, ethics committees, and competent authorities) the opportunity to have their experiences taken into account. As the results of this survey will form the basis for the European Commission Directorate Entreprise for their decisions on areas to be changed in the new clinical trials legislation it is very important that we collect as much information as possible. WE NEED YOUR SUPPORT!!!!
Please go to www.eortc.be/icrel and complete the questionnaire suitable for your type of organization.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
